At this year’s RSNA in Chicago, November 26-30, ContextVision puts their success story Altumira in the spotlight — adding new, impressive features to an already exceptional image enhancement solution.
Ever since they started out in 1983 in Linköping, Sweden, ContextVision’s innovative solutions have time, and time again set new standards in medical image enhancement. Forty years later, they continue to break new ground, driven by the same untiring passion and innovative thinking that have made them leaders within their field.
With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong performance is driven by a healthy core business supported by investments in growth initiatives such as the AI-based X-ray solution, Altumira. STOCKHOLM – October 26, 2023. […]
ContextVision is pleased to announce the appointment of Richard Hallström as a Chief Financial Officer (CFO), effective today 28th of August. He succeeds Markus Hökerberg, who has acted as an Interim CFO.
On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of this background and in line with the board’s recommendation, the Meeting resolved on a dividend […]
STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:
STOCKHOLM – March 30th, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today presents their Annual Report for 2022. The Annual Report gives additional information about the record year, where net sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%. 2022 was […]